PubRank
Search
About
Marc Bonneville
Author PubWeight™ 58.16
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human γδ T-cell subset.
Blood
2012
2.57
2
Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells.
Proc Natl Acad Sci U S A
2004
2.49
3
Tumor recognition following Vgamma9Vdelta2 T cell receptor interactions with a surface F1-ATPase-related structure and apolipoprotein A-I.
Immunity
2005
2.08
4
Selection of T cell clones expressing high-affinity public TCRs within Human cytomegalovirus-specific CD8 T cell responses.
J Immunol
2005
2.04
5
Combination of MHC-peptide multimer-based T cell sorting with the Immunoscope permits sensitive ex vivo quantitation and follow-up of human CD8+ T cell immune responses.
J Immunol Methods
2002
1.57
6
In vivo immunomanipulation of V gamma 9V delta 2 T cells with a synthetic phosphoantigen in a preclinical nonhuman primate model.
J Immunol
2005
1.57
7
Self/non-self discrimination by human gammadelta T cells: simple solutions for a complex issue?
Immunol Rev
2007
1.50
8
V gamma 9V delta 2 T cell response to colon carcinoma cells.
J Immunol
2005
1.45
9
γδ T cells: first line of defense and beyond.
Annu Rev Immunol
2014
1.44
10
The molecular basis for modulation of human Vγ9Vδ2 T cell responses by CD277/butyrophilin-3 (BTN3A)-specific antibodies.
J Biol Chem
2012
1.34
11
Structural bases for the affinity-driven selection of a public TCR against a dominant human cytomegalovirus epitope.
J Immunol
2009
1.30
12
Coordinated expression of Ig-like inhibitory MHC class I receptors and acquisition of cytotoxic function in human CD8+ T cells.
J Immunol
2004
1.26
13
Potentiation of antigen-stimulated V gamma 9V delta 2 T cell cytokine production by immature dendritic cells (DC) and reciprocal effect on DC maturation.
J Immunol
2006
1.25
14
Direct killing of Epstein-Barr virus (EBV)-infected B cells by CD4 T cells directed against the EBV lytic protein BHRF1.
Blood
2003
1.22
15
CXCR5 identifies a subset of Vgamma9Vdelta2 T cells which secrete IL-4 and IL-10 and help B cells for antibody production.
J Immunol
2006
1.19
16
Selection of high-avidity CD8 T cells correlates with control of hepatitis C virus infection.
Hepatology
2008
1.14
17
Impact of TCR reactivity and HLA phenotype on naive CD8 T cell frequency in humans.
J Immunol
2010
1.11
18
Early triggering of exclusive IFN-gamma responses of human Vgamma9Vdelta2 T cells by TLR-activated myeloid and plasmacytoid dendritic cells.
J Immunol
2009
1.09
19
CD4 engagement by CD1d potentiates activation of CD4+ invariant NKT cells.
Blood
2007
1.09
20
Prevalent role of TCR alpha-chain in the selection of the preimmune repertoire specific for a human tumor-associated self-antigen.
J Immunol
2003
1.07
21
Dominant TCR V alpha usage by virus and tumor-reactive T cells with wide affinity ranges for their specific antigens.
Eur J Immunol
2002
1.07
22
NKG2D costimulates human V gamma 9V delta 2 T cell antitumor cytotoxicity through protein kinase C theta-dependent modulation of early TCR-induced calcium and transduction signals.
J Immunol
2010
1.02
23
IL-21-mediated potentiation of antitumor cytolytic and proinflammatory responses of human V gamma 9V delta 2 T cells for adoptive immunotherapy.
J Immunol
2009
1.01
24
Discrimination between the main activating and inhibitory killer cell immunoglobulin-like receptor positive natural killer cell subsets using newly characterized monoclonal antibodies.
Immunology
2009
1.01
25
Kinetic evidence for a ligand-binding-induced conformational transition in the T cell receptor.
Proc Natl Acad Sci U S A
2007
0.98
26
Bridging innate and adaptive immunity through gammadelta T-dendritic cell crosstalk.
Front Biosci
2008
0.94
27
Up-regulation of cytolytic functions of human Vδ2-γ T lymphocytes through engagement of ILT2 expressed by tumor target cells.
Blood
2011
0.93
28
Long-term MHC class II presentation of the EBV lytic protein BHRF1 by EBV latently infected b cells following capture of BHRF1 antigen.
J Immunol
2005
0.93
29
Human Vgamma9Vdelta2 T cells: from signals to functions.
Semin Immunol
2010
0.92
30
Uncoupling between immunological synapse formation and functional outcome in human gamma delta T lymphocytes.
J Immunol
2003
0.91
31
Enumeration of antigen-specific CD8+ T lymphocytes by single-platform, HLA tetramer-based flow cytometry: a European multicenter evaluation.
Cytometry B Clin Cytom
2004
0.90
32
Repeated systemic administrations of both aminobisphosphonates and human Vγ9Vδ2 T cells efficiently control tumor development in vivo.
J Immunol
2013
0.89
33
+1 Frameshifting as a novel mechanism to generate a cryptic cytotoxic T lymphocyte epitope derived from human interleukin 10.
J Exp Med
2002
0.88
34
Cross-reactivity of herpesvirus-specific CD8 T cell lines toward allogeneic class I MHC molecules.
PLoS One
2010
0.86
35
T cell re-targeting to EBV antigens following TCR gene transfer: CD28-containing receptors mediate enhanced antigen-specific IFNgamma production.
Int Immunol
2006
0.85
36
EBV-specific CD4+ T cell clones exhibit vigorous allogeneic responses.
J Immunol
2006
0.84
37
Modulation of HLA-A*0201-restricted T cell responses by natural polymorphism in the IE1(315-324) epitope of human cytomegalovirus.
J Immunol
2003
0.83
38
Assessment of CD8 involvement in T cell clone avidity by direct measurement of HLA-A2/Mage3 complex density using a high-affinity TCR like monoclonal antibody.
Eur J Immunol
2005
0.83
39
Ex vivo measurement of the cytotoxic capacity of human primary antigen-specific CD8 T cells.
J Immunol Methods
2011
0.83
40
Ex vivo development of functional human lymph node and bronchus-associated lymphoid tissue.
Blood
2002
0.82
41
NK-KIR transcript kinetics correlate with acute graft-versus-host disease occurrence after allogeneic bone marrow transplantation.
Hum Immunol
2005
0.80
42
Impact of CD8-MHC class I interaction in detection and sorting efficiencies of antigen-specific T cells using MHC class I/peptide multimers: contribution of pMHC valency.
Int Immunol
2006
0.80
43
Allelic exclusion at the TCR delta locus and commitment to gamma delta lineage: different modalities apply to distinct human gamma delta subsets.
J Immunol
2004
0.80
44
Characterization of the human CD4(+) T-cell repertoire specific for major histocompatibility class I-restricted antigens.
Eur J Immunol
2013
0.79
45
Cross-reactivity of HLA-B*1801-restricted T-lymphocyte clones with target cells expressing variants of the human cytomegalovirus 72kDa-IE1 protein.
J Virol
2003
0.78
46
Selection of intraepithelial gammadelta cells: the Holy GrIEL at last?
Nat Immunol
2006
0.78
47
Full restoration of Brucella-infected dendritic cell functionality through Vγ9Vδ2 T helper type 1 crosstalk.
PLoS One
2012
0.78
48
Modulation of inflammation through IL-17 production by gammadelta T cells: mandatory in the mouse, dispensable in humans?
Immunol Lett
2009
0.78
49
Crystallization and preliminary X-ray crystallographic characterization of a public CMV-specific TCR in complex with its cognate antigen.
Acta Crystallogr Sect F Struct Biol Cryst Commun
2009
0.78
50
Focus on the controversial activation of human iNKT cells by 4-deoxy analogue of KRN7000.
J Med Chem
2009
0.78
51
Complex interplay of activating and inhibitory signals received by Vgamma9Vdelta2 T cells revealed by target cell beta2-microglobulin knockdown.
J Immunol
2006
0.76
52
Search for correlation of CD8 T cell response to Epstein-Barr virus with clinical status in rheumatoid arthritis: a 15 month followup pilot study.
J Rheumatol
2003
0.76
53
Activated iNKT cells promote Vγ9Vδ2-T cell anti-tumor effector functions through the production of TNF-α.
Clin Immunol
2011
0.76
54
Impact of Graft-versus-Graft Natural Killer Cell Alloreactivity on Single Unit Dominance After Double Umbilical Cord Blood Transplantation.
Transplantation
2016
0.76
55
Thymic signatures of tailored peripheral functions.
Nat Immunol
2012
0.75
56
CD8: from coreceptor to comodulator.
Nat Immunol
2002
0.75
57
Science and society: promoting the learning of immunology in developing countries.
Nat Rev Immunol
2005
0.75